In addition, these specific anti-tumor actions of Calebin A further correlated with inhibition of cell metastatic (CXCR4, MMP-9) and proliferative (cyclin D1) biomarkers, all of which are known to have a NF-κB binding site in their promoters, thus promoting their transcription. Here, NFKB1 is linked to neoplasm.